5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy

Jiang, S., Sydney, E. J., Runyan, A. M., Serpe, R., Srikanth, M., Figueroa, H. Y., Yang, M., & Myeku, N. (2024). 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy. Frontiers in Cellular Neuroscience, 18. https://doi.org/10.3389/fncel.2024.1338502
Authors:
Shan Jiang
Eric J Sydney
Avery M Runyan
Rossana Serpe
Malavika Srikanth
Helen Y Figueroa
Mu Yang
Natura Myeku
Affiliated Authors:
Shan Jiang
Eric J Sydney
Avery M Runyan
Rossana Serpe
Malavika Srikanth
Helen Y Figueroa
Mu Yang
Natura Myeku
Columbia Affiliation:
Subjects:
Mechanisms of Alzheimer's Disease (OpenAlex Topic)
Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders (OpenAlex Topic)
Role of Microglia in Neurological Disorders (OpenAlex Topic)
Author Keywords:
alzheimer's disease
ubiquitin proteasome system (ups)
tauopathy
5-ht4 agonist
synaptic therapy
alzheimer’s disease
elink
Publication Type:
Article
Unique ID:
10.3389/fncel.2024.1338502
PMID:
38638303
DOI:
10.3389/fncel.2024.1338502
Journal:
Frontiers in Cellular Neuroscience
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record
View Web of Science Record

Record Created: